KLHL11 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.522200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.397400E-01
Normal-vs-Stage2
5.309600E-01
Normal-vs-Stage3
1.119600E-01
Normal-vs-Stage4
6.371400E-01
Stage1-vs-Stage2
9.870300E-02
Stage1-vs-Stage3
1.157040E-01
Stage1-vs-Stage4
9.697600E-01
Stage2-vs-Stage3
1.678420E-01
Stage2-vs-Stage4
1.455580E-01
Stage3-vs-Stage4
3.416300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.582000E-01
Normal-vs-AfricanAmerican
8.748000E-01
Normal-vs-Asian
1.886760E-01
Caucasian-vs-AfricanAmerican
5.028000E-01
Caucasian-vs-Asian
2.275200E-01
AfricanAmerican-vs-Asian
8.661700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.792400E-01
Normal-vs-Female
8.443400E-01
Male-vs-Female
4.906000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.619000E-01
Normal-vs-Age(41-60Yrs)
9.890200E-01
Normal-vs-Age(61-80Yrs)
6.811200E-01
Normal-vs-Age(81-100Yrs)
4.526100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.052000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.640800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.968800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.379760E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.830200E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.819900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.266820E-01
Normal-vs-Daily Drinker
3.273800E-02
Normal-vs-Weekly Drinker
6.751000E-01
Normal-vs-Occasional Drinker
8.433400E-01
Normal-vs-Social Drinker
7.797200E-01
Non Drinker-vs-Daily Drinker
2.359400E-01
Non Drinker-vs-Weekly Drinker
3.242800E-01
Non Drinker-vs-Occasional Drinker
5.414200E-02
Non Drinker-vs-Social Drinker
9.335900E-02
Daily Drinker-vs-Weekly Drinker
1.208030E-01
Daily Drinker-vs-Occasional Drinker
1.986200E-02
Daily Drinker-vs-Social Drinker
4.774000E-02
Weekly Drinker-vs-Occasional Drinker
3.371800E-01
Weekly Drinker-vs-Social Drinker
2.967400E-01
Occasional Drinker-vs-Social Drinker
8.094600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.356600E-01
Normal-vs-Grade 2
9.818000E-02
Normal-vs-Grade 3
4.646500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.057030E-01
Grade 1-vs-Grade 3
1.098020E-01
Grade 1-vs-Grade 4
2.356600E-01
Grade 2-vs-Grade 3
9.923000E-01
Grade 2-vs-Grade 4
9.818000E-02
Grade 3-vs-Grade 4
4.646500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.969000E-01
Normal-vs-NonDiabetic
7.548800E-01
Diabetic-vs-NonDiabetic
3.278000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.122440E-01
Normal-vs-NoPancreatitis
7.540800E-01
Pancreatitis-vs-NoPancreatitis
4.042200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.288800E-01
Normal-vs-N1
5.782000E-01
N0-vs-N1
3.982000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.012600E-01
Normal-vs-TP53-NonMutant
7.617800E-01
TP53-Mutant-vs-TP53-NonMutant
1.302310E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
